Barely Significant
← all phrases

“a clear trend”

19,461 sentences · 19,461 papers · 31,348 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a clear trendp = 0.0971.9× alphagold
Results At 3 months postoperatively, patients who had undergone surgery in 2020 showed a clear trend towards a higher frequency of extension deficits of ≥ 5° (18.8% vs. 4.3%, p = 0.097) or an inability to bend the knee ≥ 120° (23.3% vs. 10%, p = 0.197) compared to those who had received surgery in 2019.
a clear trendP = .0971.9× alphagold
At 3 months postsurgery, patients who had undergone surgery in 2020 showed a clear trend toward a higher frequency of extension deficits of ≥5° (18.8% vs 4.3%, respectively; P = .097) or an inability to bend the knee ≥120° (23.3% vs 10%, respectively; P = .197) compared with those who had undergone surgery in 2019.
As shown in Figure 6D , although the improvement in survival rate of mice treated with XBJ and Hydroxysafflor Yellow A did not reach statistical significance compared to the PBS group (possibly due to the limited sample size or insufficient observation duration), the XBJ group exhibited a clear trend toward prolonged survival (HR = 0.361, P = 0.097) and demonstrated the strongest protective effect, with a survival rate at the endpoint twice that of the PBS group.
a clear trendp = 0.0992.0× alphagold
A clear trend towards upregulation of the skin barrier proteins involucrin (IVL, 1.4-fold; p = 0.099; Fig. 2b ) and loricrin (LOR, 1.6-fold; p = 0.5218; Fig. 2c ), as well as the tight junction proteins occludin (OCLN, 1.4-fold, Fig. 2d ) and claudin-1 (CLDN-1, 1.2-fold, p = 0.036, Fig. 2e ) in FLG − compared to FLG + skin equivalents was observed, in line with previous reports from our group 13 .
a clear trendP = 0.102.0× alphagold
Under conditions where vesicular 5-HT accumulation was inhibited by Tbz, citalopram was similarly effective (EC 50 = 94.5 nM; 46.0–194.3 nM; 95% C.I.; log IC 50 not different from Ctrl, P = 0.58, F = 0.32, extra sum-of-squares F test), although a clear trend toward weaker maximal effect was observed (fit bottom = 26.7%; 9.7–43.6%; 95% C.I.; not different from Crtl, P = 0.10, F = 2.71, extra sum-of-squares F test).
a clear trendp = 0.102.0× alphagold
On the other hand, patients with severe impairment of the renal function (eGFR < 30 ml/min/1.73m 2 ) showed a clear trend to more likely develop DRT (13.3% vs. 5.1%, p = 0.10), as compared to the opposite group, Fig. 3 a and b.